
Find Reports
Select Report Type
Reimbursement Review
Displaying 776 - 800 of 1426
Please scroll or swipe to the right to view the full content.
Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
---|---|---|---|---|---|---|---|---|---|
Fluticasone furoate /vilantero... | Breo Ellipta | Fluticasone furoate /vilanterol | Chronic Obstructive Pulmonary Disease (COPD) | List with criteria/condition | Complete | SR0358-000 | |||
Sofosbuvir | Sovaldi | Sofosbuvir | Hepatitis C, chronic | List with criteria/condition | Complete | SR0356-000 | |||
Pomalyst for Multiple Myeloma ... | Pomalyst | Pomalidomide | Multiple Myeloma | Reimburse with clinical criteria and/or conditions | Complete | PC0036-000 | |||
Riociguat | Adempas | Riociguat | Chronic thromboembolic pulmonary hypertension | List with criteria/condition | Complete | SR0353-000 | |||
Golimumab | Simponi I.V. | Golimumab | Arthritis, rheumatoid | List with criteria/condition | Complete | SR0351-000 | |||
Saxagliptin + Metformin | Komboglyze | Saxagliptin + metformin | Diabetes Mellitus, type 2 | List with criteria/condition | Complete | SR0348-000 | |||
Simeprevir | Galexos | Simeprevir | Hepatitis C, chronic | List with criteria/condition | Complete | SR0347-000 | |||
Teriflunomide | Aubagio | Teriflunomide | Multiple sclerosis, relapsing-remitting | Do not list at the submitted price | Complete | SR0350-000 | |||
OnabotulinumtoxinA | Botox | OnabotulinumtoxinA | Migraine | Do not list | Complete | SR0345-000 | |||
Rotigotine | Neupro | Rotigotine | Parkinson's disease | Do not list | Complete | SR0344-000 | |||
Giotrif for Advanced Non Small... | Giotrif | Afatinib | Advanced or Metastatic Non-Small Cell Lung Cancer | Reimburse | Complete | PC0032-000 | |||
Stivarga for Gastrointestinal ... | Stivarga (GIST) | Regorafenib | Gastrointestinal Stromal Tumour | Reimburse with clinical criteria and/or conditions | Complete | PC0034-000 | |||
Eplerenone | Inspra | Eplerenone | Heart failure, NYHA class II | Do not list at the submitted price | Complete | SR0342-000 | |||
Aclidinium bromide | Tudorza Genuair | Aclidinium bromide | Chronic Obstructive Pulmonary Disease | List with criteria/condition | Complete | SR0346-000 | |||
Rivaroxaban | Xarelto | Rivaroxaban | Venous thromboembolic events, pulmonary embolism | List with criteria/condition | Complete | SR0327-000 | |||
Tocilizumab | Actemra | Tocilizumab | Arthritis, polyarticular juvenile idiopathic | List with criteria/condition | Complete | SR0343-000 | |||
Golimumab | Simponi | Golimumab | Ulcerative colitis | Do not list at the submitted price | Complete | SR0341-000 | |||
Trisenox for Acute Promyelocyt... | Trisenox | Arsenic Trioxide | Acute Promyelocytic Leukemia | Reimburse | Complete | PC0033-000 | |||
Ingenol mebutate | Picato | Ingenol mebutate | Actinic keratosis | Do not list | Complete | SR0330-000 | |||
Erbitux for Metastatic Colorec... | Erbitux | Cetuximab | Metastatic Colorectal Cancer | Do not reimburse | Complete | PC0031-000 | |||
Vismodegib (Erivedge) for Adva... | Erivedge | Vismodegib | Basal Cell Carcinoma | Reimburse with clinical criteria and/or conditions | Complete | PC0015-000 | |||
Trastuzumab emtansine for Meta... | Kadcyla | Trastuzumab emtansine | Advanced or Metastatic Breast Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0024-000 | |||
Lurasidone | Latuda | Lurasidone | Schizophrenia | List with criteria/condition | Complete | SR0331-000 | |||
Somatropin | Genotropin | Somatropin | Growth hormone deficiency, adult | List with criteria/condition | Complete | SR0332-000 | |||
Somatropin | Genotropin | Somatropin | Growth hormone deficiency, children | List with criteria/condition | Complete | SR0333-000 |
Health Technology Review
Displaying 601 - 602 of 602
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 776 - 800 of 2138
Please scroll or swipe to the right to view the full content.
Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
---|---|---|---|---|---|---|---|
Delayed Tuberculin Skin Testing | Health Technology Review | Rapid Review | Completed | RC1452-000 | |||
selpercatinib | Reimbursement Review | Complete | PC0274-000 | ||||
Internet-Delivered Cognitive Behavioural Therapy in the Treatment of Chronic Non-Cancer Pain | Health Technology Review | Optimal Use | Completed | HT0037-000 - OP0550-000 | |||
Cannabis for Opioid Use Disorder | Health Technology Review | Rapid Review | Completed | RC1454-000 | |||
lisocabtagene maraleucel | Reimbursement Review | Complete | PG0258-000 | ||||
Real Time Continuous Glucose Monitoring for People Living with Type 2 Diabetes | Health Technology Review | Rapid Review | Completed | RC1443-000 | |||
elexacaftor/tezacaftor/ivacaftor and ivacaftor | Reimbursement Review | Complete | SR0710-000 | ||||
zanubrutinib | Reimbursement Review | Complete | PC0267-000 | ||||
Mepivacaine Versus Bupivacaine for Patients Undergoing Total Joint Arthroplasty | Health Technology Review | Rapid Review | Completed | RC1453-000 | |||
Vagus Nerve Stimulation for the Treatment of Post–COVID-19 Condition | Horizon Scan | Health Technology Update | Active | EN0040-000 | |||
Therapeutic Support for Pressure Injuries | Health Technology Review | Rapid Review | Completed | RC1450-000 | |||
Airway Pressure Release Ventilation for Acute Respiratory Distress Syndrome: An Update | Health Technology Review | Rapid Review | Completed | RC1451-000 | |||
cenegermin | Reimbursement Review | Complete | SR0704-000 | ||||
avalglucosidase alfa | Reimbursement Review | Complete | SR0703-000 | ||||
Antiviral Prophylaxis With Tenofovir for Patients With History of Hepatitis B Receiving Oncology Drug Treatment | Health Technology Review | Rapid Review | Completed | RC1448-000 | |||
RWE Learning Project Non-Oncology: Ocaliva | Health Technology Review | Technology Review | In Progress | HC0046-000 | |||
Renal Cell Carcinoma (RCC) | Reimbursement Review | Provisional Funding Algorithm | Complete | PH0013-000 | |||
tirzepatide | Reimbursement Review | Cancelled | SR0751-000 | ||||
Considerations for the use of COVID-19 Rapid Tests | Health Technology Review | Environmental Scan | Completed | ES0364-000 | |||
Utilization of Glucagon-Like Peptide-1 Receptor Agonists | Health Technology Review | Technology Review | Completed | HC0042-000 | |||
CADTH Pharmaceutical Reviews Update — Issue 31 | Reimbursement Review | Pharmaceutical Review Update | |||||
cemiplimab | Reimbursement Review | Complete | PC0262-000 | ||||
amifampridine phosphate | Reimbursement Review | Complete | SR0664-000 | ||||
tafamidis | Reimbursement Review | Complete | SF0722-000 | ||||
Real-Time Continuous Glucose Monitoring for People Living With Type 1 Diabetes | Health Technology Review | Rapid Review | Completed | RC1442-000 |
Provisional Funding Algorithm
Displaying 76 - 81 of 81